PanTum® Detect is a multi-tumor screening blood test that “filters” asymptomatic healthy individuals by screening for the presence of silently growing benign, premalignant or malignant tumors.
The test has an IVD CE certified sensitivity of 97.5% and a specificity of 99%. It uses EDIM® (Epitope Detection in Monocytes) technology to detect multi-tumor enzyme biomarkers Apo10 and TKTL1 in immune cells (macrophages) which are detectable in all phases of tumor development.
This revolutionary, thoroughly researched and scientifically proven technology leverages our innate immune system thus making it possible to detect tumors in early stages.
The “Cancer-Scan” program combines pre-testing with PanTum® Detect and confirmatory cancer detection diagnostics (advanced imaging techniques and diagnostic pathology) for those who test positive with PanTum® Detect into an integrated multi-tumor screening concept for “timely” detection of tumors.
The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.